Learn More
Medchemexpress LLC Cdc42-IN-1 | 1222513-26-9 | 99.8% | 486.38 | 50 MG

Supplier: Medchemexpress LLC HY13637950MG
CID44216842 (Cdc42-IN-1) is a potent and selective guanine nucleotide binding lead inhibitor targeting Cdc42. It functions as a molecular probe, specifically inhibiting GTP binding to both Cdc42 and its mutant in a dose-dependent manner. This inhibition is specific toward Cdc42 with no effects on other GTPases including Rac and Rho in the same family.
- Potent Cdc42-selective guanine nucleotide binding lead inhibitor
- EC50s for Cdc42 WT and Cdc42Q61L mutant are 1.0 and 1.2 μM in GTP binding assay
- EC50s for Cdc42 WT and Cdc42Q61L mutant are 0.3 and 0.5 μM in GDP binding assay
- Used as a molecular probe
- Specific inhibition of Cdc42 without affecting other GTPases like Rac and Rho
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.